MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease

    G. Hall-Mcmaster, N. Slater, K-L. Horne, A. Harris, R. Shoorangiz, T. Anderson, N. Pat, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To examine periodic and aperiodic EEG correlates of cognition in Parkinson’s disease (PD). Background: Quantitative EEG metrics are increasingly used to describe variations in…
  • 2024 International Congress

    Neuropsychological Tests of Language, Memory, and Visuospatial Function in Parkinson’s Disease: Review, Critique and Recommendations

    O. Bezdicek, R. Biundo, D. Cammisuli, B. Cholerton, J. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, S. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Praha, Czech Republic)

    Objective: To evaluate the psychometric properties of Language, Memory, and Visuospatial Function tests in Parkinson’s Disease (PD) on behalf of the Movement Disorder Society (MDS)…
  • 2024 International Congress

    Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology

    N. Lipari, I. Sandoval, F. Manfredsson, C. Bishop (Binghamton, USA)

    Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…
  • 2024 International Congress

    The Effect of an Exogenous Ketone Supplement on Gut Microbiota in Parkinson’s disease, a Pilot Study

    V. Vedam-Mai, M. Beke, V. Mai, P. Mackie, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)

    Objective: To investigate the effect of exogenous oral ketone esters on gut microbiota in people with PD. Background: Mitochondrial dysfunction in the substantia nigra and…
  • 2024 International Congress

    Unwinding Anxiety: Feasibility and Effectiveness of App-Based Mindfulness Training for People with Anxiety and Parkinson’s Disease: A Pilot Study

    E. Weisbach, A. Demarco, J. Molino, A. Seritan, P. Prakash (Providence, USA)

    Objective: To assess whether an app-based mindfulness training (MT) intervention, “Unwinding Anxiety”, can be used for Parkinson’s Disease (PD) patients with mild-moderate anxiety to reduce…
  • 2024 International Congress

    Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)

    I. Muro, L. López-Manzanares, P. Lorenzo, E. Casas, B. González, J. Masabanda, A. Arroyo, A. Hurtado, JP. Romero (Madrid, Spain)

    Objective: To outline the protocol for an upcoming study aimed at describing the non-motor symptoms (NMS) in Parkinson’s disease (PD) patients with heterozygous glucocerebrosidase (GBA)…
  • 2024 International Congress

    Parkinson’s disease biomarkers in human olfactory cleft mucus

    J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)

    Objective: To investigate and identify biomarkers for PD from human olfactory cleft mucus Background: Olfactory loss is an early symptom of PD, often preceding motor…
  • 2024 International Congress

    The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder

    E. Sandoval, C. Josephs, T. Lin (Tucson, USA)

    Objective: 1. To determine the co-occurrence rate of PTSD in veterans with PD and RBD.2. To evaluate severity of dream enactment behavior (DEB) and rate…
  • 2024 International Congress

    Influence of Fatigue in Parkinson’s Disease on Variability of Gait Measures

    I. Sierra, S. Perfetto, A. Potvin-Desrochers, C. Mvomo, J. Bedime, H. Lajeunesse, F. Parent-L'Ecuye, C. Paquette (Montreal, Canada)

    Objective: This project aims to explore the experience of fatigue in Parkinson’s patients, and its influence on gait variability in stride frequency and ground contact…
  • 2024 International Congress

    Obsessive-Compulsive Disorder Prevalence in Parkinson’s Disease Caregivers

    F. Hojjatipour, M. Salari (tehran, Islamic Republic of Iran)

    Objective: Our goal is to assess the prevalence of obsessive-compulsive disorder (OCD) among those who provide care for individuals with Parkinson's disease (PD). Additionally, we…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley